Medication Subsidy (PBAC), Medications and Treatments, NMOSD, Pharmaceutical Benefits Advisory Committee, PBAC Re-submission of Soliris (eculizumab) for NMOSD to PBAC meeting November 20212021-09-222024-09-05https://msra.org.au/wp-content/uploads/2016/03/MSRA-logo.jpgMS Australiahttps://msra.org.au/wp-content/uploads/2016/03/MSRA-logo.jpg200px200px